Avior Bio, Inc.
PrivateLast Round
Debt
Nov 1, 2022
Total Funding Raised
$2.76M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avior Bio, Inc. is a pharmaceutical company that develops drug delivery technology and therapeutic treatments for neurological conditions and pruritus.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avior Bio, Inc. Comparables
Compare Avior Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CURE Pharmaceutical | 82% | |
| Rapid Dose Therapeutics Corp. | 78% | |
| Aavishkar Oral Strips | 77% |
Avior Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Nov 1, 2022 | ||||
| Grant | Jul 1, 2021 | ||||
| Seed | Feb 22, 2021 | ||||
| Debt | Nov 1, 2020 | ||||
| Pre Seed | Jul 28, 2020 | ||||
Debt | Jul 28, 2020 |
Avior Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| North Carolina Biotechnology Center | Debt |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 266% MoM, reaching 1.4K.
- Apr 15, 2026
Monthly visitors grew 1071% MoM, reaching 1.6K.
Avior Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avior Bio, Inc.'s valuation, stock price, and market status.
Is Avior Bio, Inc. a public or private company?
Avior Bio, Inc. is a private company.
What is the current stock price of Avior Bio, Inc.?
Avior Bio, Inc. is a private company with no public stock price. Caplight tracks Avior Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Avior Bio, Inc. worth (valuation)?
Valuation information for Avior Bio, Inc. is not publicly available.
Can I buy Avior Bio, Inc. stock?
Avior Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avior Bio, Inc.'s last funding round?
Avior Bio, Inc.'s most recent funding round was Debt on November 1, 2022.
Who are the main investors in Avior Bio, Inc.?
Key investors in Avior Bio, Inc. include National Institute on Drug Abuse, North Carolina Biotechnology Center, National Institutes of Health (NIH), National Science Foundation.
Will Avior Bio, Inc. IPO soon?
No public IPO plans have been announced for Avior Bio, Inc..
How can I track Avior Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avior Bio, Inc.'s secondary market activity and sign up for updates.